Prostate-specific antigen (PSA) was detected in microtitre wells coated with a PSA-specific antibody using biotinylated antibody and streptavidin-coated, highly fluorescent 107 nm nanoparticles, which contained more than 30000 europium ions entrapped by b-diketones. PSA was monitored directly on the
Prostate-specific antigen detection by ultrasensitive assay in samples from women
✍ Scribed by Filella, Xavier; Molina, Rafael; Alcover, Juan; Menéndez, Violeta; Giménez, Núria; Jo, Judith; Carretero, Pablo; Ballesta, Antonio Manuel
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 505 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0270-4137
No coin nor oath required. For personal study only.
✦ Synopsis
Background:
The prostate specific antigen (psa) has been characterized as a specific prostate marker. recent studies have indicated the existence of a psa of nonprostatic origin detected in lactating women and breast tumors.
Methods:
We have evaluated the presence of psa by an ultrasensitive assay (cobas core) in 252 serum and non serum samples from women.
Results:
The results demonstrate the presence of psa in 100% of the breast secretions, 81% of the breast cysts, 80% of the bronchoalveolar lavage fluids and 71% of the cytosols of breast cancer. likewise, psa was detected in 14% of the sera evaluated, although the concentrations were always lower than 0.5 ng/ml.
Conclusions:
We conclude that psa should not continue being considered as the specific prostate tissue marker although, given that the serum concentrations detected are very low, they do appear to interfere to a minimum extent in the usefulness of psa as a tumor marker.
📜 SIMILAR VOLUMES
Detection of illegitimate transcripts of prostate-specific antigen